T

he drug industry spends billions each year to promote its medicines to the masses, blanketing popular TV shows and magazines with ads. Now, digital companies are increasingly trying to pry away a share of that money for ads that target specific patients, rather than broad demographics.

Targeted ads are nothing new in retail; anyone who uses the internet has had the eerie feeling that the ads popping up on page after page appear to be aimed directly at them. But drug makers have long steered clear of many such tools, for fear of violating patient privacy law.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy